Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-04

Clinical Trial Update: Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy [Phase 4]

View source ↗

Summary

Phase 4 randomized, placebo-controlled trial evaluating lubiprostone as preparation for capsule endoscopy in inflammatory bowel disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUBIPROSTONE (lubiprostone)

Snippet

Sponsor: University of South Alabama | Conditions: Inflammatory Bowel Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-01-04